Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study

• Main Authors: Tsuruta A (Author), Yamashita K (Author), Tanioka H (Author), Tsuji A (Author), Inukai M (Author), Yamakawa T (Author), Yamatsuji T (Author), Yoshimitsu M (Author), Toyota K (Author), Yamano T (Author), Nagasaka T (Author), Okajima M (Author)
• Format: Book
• Published: Dove Medical Press, 2016-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Atsushi Tsuruta,1,* Kazuki Yamashita,2,* Hiroaki Tanioka,3 Akihito Tsuji,4,5 Michio Inukai,6 Toshiki Yamakawa,7 Tomoki Yamatsuji,8 Masanori Yoshimitsu,9 Kazuhiro Toyota,10 Taketoshi Yamano,11 Takeshi Nagasaka,12 Masazumi Okajima13 On behalf of the Japan Southwest Oncology Group (JSWOG) 1Department o...